Apellis Pharmaceuticals (APLS) Shares Issued (2020 - 2025)
Historic Shares Issued for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to $797000.0.
- Apellis Pharmaceuticals' Shares Issued fell 6881.85% to $797000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 8538.77%. This contributed to the annual value of $14.3 million for FY2024, which is 7991.41% down from last year.
- According to the latest figures from Q3 2025, Apellis Pharmaceuticals' Shares Issued is $797000.0, which was down 6881.85% from $4.4 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Shares Issued ranged from a high of $380.1 million in Q1 2022 and a low of $281000.0 during Q1 2025
- Moreover, its 5-year median value for Shares Issued was $5.1 million (2023), whereas its average is $53.2 million.
- As far as peak fluctuations go, Apellis Pharmaceuticals' Shares Issued plummeted by 9932.18% in 2021, and later soared by 1458778.98% in 2022.
- Apellis Pharmaceuticals' Shares Issued (Quarter) stood at $368.2 million in 2021, then rose by 3.23% to $380.1 million in 2022, then crashed by 93.3% to $25.5 million in 2023, then plummeted by 98.74% to $321000.0 in 2024, then soared by 148.29% to $797000.0 in 2025.
- Its last three reported values are $797000.0 in Q3 2025, $4.4 million for Q2 2025, and $281000.0 during Q1 2025.